Search Results 1-10 of 15862 for brca1%20and%20brca2%20genes%20and%20breast%20cancer
-
Find out what to expect if you're considering a blood test to determine if you have an increased risk of breast cancer. Learn what your results might mean.
-
The purpose of this trial is to compare denosumab to placebo for the prevention of breast cancer in women with a BRCA1 germline mutation. A germline ...
-
A germline mutation is an inherited gene change which, in the BRCA1 gene, is associated with an increased risk of breast and other cancers. Denosumab is a ...
-
James W. Jakub, M.D., Breast Surgeon, Mayo Clinic: Patients with a genetic mutation that increase the risk of developing breast cancer have many options to ...
-
About this study. Olaparib treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed ...
-
Monogenic risk of breast cancer can be due to variants in any one of these genes: BRCA1. BRCA2. PALB2. PTEN. TP53. For participants with monogenic risk, the ...
-
Find out what to expect if you're considering a blood test to determine if you have an increased risk of breast cancer. Learn what your results might mean.
-
This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
-
Here are some things to think about as you decide whether genetic testing for BRCA1, BRCA2 or the many other genes related to breast cancer is right for you.
-
This randomized phase II trial studies how well cisplatin works with or without veliparib in treating patients with triple-negative breast cancer and/or BRCA ...